12/20/2024
7:30 PM | Applied Therapeutics (Issuer)
JOHNSON JOHN (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
12/20/2024
7:30 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
7:30 PM | Applied Therapeutics (Issuer)
JOHNSON JOHN (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/20/2024
6:07 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/06/2024
10:36 AM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SCHEDULE 13G/A | |
12/02/2024
4:15 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/14/2024
4:47 PM | Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
|
11/14/2024
3:50 PM | Applied Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
| Form SC 13G/A | |
11/13/2024
3:15 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
11/08/2024
1:17 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
11/07/2024
6:30 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/07/2024
6:19 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:38 PM | Applied Therapeutics (Subject)
MORGAN STANLEY (Filed by)
| Form SC 13G | |
10/31/2024
11:42 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SCHEDULE 13G/A | |
10/24/2024
1:02 PM | Applied Therapeutics (Subject)
BlackRock, Inc. (Filed by)
| Form SC 13G | |
08/23/2024
3:33 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/23/2024
3:35 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/14/2024
5:52 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
08/14/2024
6:01 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
7:43 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/07/2024
6:08 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/07/2024
6:13 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
06/10/2024
3:29 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:25 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:12 PM | Applied Therapeutics (Issuer)
MARCUS JOEL S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:13 PM | Applied Therapeutics (Issuer)
SKYLER JAY S (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/07/2024
3:17 PM | Applied Therapeutics (Issuer)
Kanter Stacy J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
5:45 PM | Alexandria Equities No. 7, LLC (Reporting)
ALEXANDRIA REAL ESTATE EQUITIES, INC. (Reporting)
Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/05/2024
3:26 PM | Alexandria Venture Investments, LLC (Reporting)
Applied Therapeutics (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024
5:10 PM | Applied Therapeutics (Subject)
Hansard Adam (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024
6:13 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
6:17 AM | Applied Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/25/2024
11:15 PM | Applied Therapeutics (Filer)
| Form EFFECT | |
04/25/2024
3:33 PM | Applied Therapeutics (Filer)
| Form 424B3 | |
04/22/2024
3:37 PM | Applied Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024
3:38 PM | Applied Therapeutics (Filer)
| Form DEFA14A | |
04/22/2024
3:39 PM | Applied Therapeutics (Filer)
| Form ARS | |
04/15/2024
4:27 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
04/15/2024
4:30 PM | Applied Therapeutics (Issuer)
Hooks Corwin Dale (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/15/2024
4:00 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/11/2024
3:41 PM | Applied Therapeutics (Filer)
| Form PRE 14A | |
We recommended Palantir in 2021, now we’re recommending this... (Ad) My research indicates there is only one investment that can meet AI's unprecedented demand for energy. Click to get the name and ticker symbol |
03/22/2024
3:31 PM | Applied Therapeutics (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
03/18/2024
4:57 PM | Applied Therapeutics (Issuer)
Funtleyder Leslie D. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:00 PM | Applied Therapeutics (Issuer)
Hansard Adam (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:02 PM | Applied Therapeutics (Issuer)
Perfetti Riccardo (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
5:12 PM | Applied Therapeutics (Issuer)
Shendelman Shoshana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/18/2024
4:49 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
03/18/2024
4:51 PM | Applied Therapeutics (Issuer)
Chinoporos Constantine (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/13/2024
3:42 PM | Applied Therapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
03/11/2024
7:17 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/08/2024
2:17 PM | Applied Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G | |
03/06/2024
6:19 AM | Applied Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/06/2024
6:12 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/05/2024
4:42 PM | Applied Therapeutics (Subject)
Shendelman Shoshana (Filed by)
| Form SC 13D/A | |
02/29/2024
3:18 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/22/2024
1:26 PM | Applied Therapeutics (Subject)
Propel Bio Management, LLC (Filed by)
| Form SC 13G/A | |
02/15/2024
6:07 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
8:20 PM | Applied Therapeutics (Subject)
Applied Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
| Form SC 13G/A | |
02/14/2024
5:30 PM | Applied Therapeutics (Subject)
ORBIMED ADVISORS LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
3:22 PM | ALEXANDRIA REAL ESTATE EQUITIES, INC. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/14/2024
1:40 PM | Applied Therapeutics (Subject)
ARMISTICE CAPITAL, LLC (Filed by)
| Form SC 13G/A | |
02/14/2024
12:50 PM | Alyeska Investment Group, L.P. (Filed by)
Applied Therapeutics (Subject)
| Form SC 13G/A | |
02/09/2024
7:35 AM | Applied Therapeutics (Subject)
FMR LLC (Filed by)
| Form SC 13G/A | |
02/06/2024
7:49 AM | Applied Therapeutics (Subject)
FRANKLIN RESOURCES INC (Filed by)
| Form SC 13G/A | |
01/03/2024
8:15 AM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/29/2023
3:23 PM | Applied Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
